| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/23/2008 | CN101165047A Glycolipid derivative and its manufacturing method, and its synthesizing intermediate and its manufacturing method |
| 04/23/2008 | CN101165037A Beta-elemene monosubstituted ether derivatives, synthesis method and use thereof |
| 04/23/2008 | CN101165036A Ether compounds, compositions, and uses thereof |
| 04/23/2008 | CN101164621A Super-paramagnetic composite particle drug-loaded body and preparation method thereof |
| 04/23/2008 | CN101164619A Pyritinol injection with special purpose solvent |
| 04/23/2008 | CN101164618A A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes |
| 04/23/2008 | CN101164594A Paste suitable for fundus disease and retinal microcirculation disease and preparation method thereof |
| 04/23/2008 | CN101164584A Method for making lung-moistening and throat-clearing lozenge |
| 04/23/2008 | CN101164575A Method for preparing spraying agent for treating seasonal dermatitis |
| 04/23/2008 | CN101164574A Medicine for treating burns and scalds and its preparation method |
| 04/23/2008 | CN101164559A Formulations useful in the treatment of male and female impotence |
| 04/23/2008 | CN101164553A Application of jin mushroom polysaccharide germanium in preparing medicine for inhibiting H5N1 avian influenza virus |
| 04/23/2008 | CN101164551A Optimization formula for liver cancer-resisting traditional Chinese medicine active ingredient |
| 04/23/2008 | CN101164549A External-applied medicine for treating acne and manufacturing method thereof |
| 04/23/2008 | CN101164548A Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 04/23/2008 | CN101164547A Application of pennogenin in preparing hemostatic medicines |
| 04/23/2008 | CN101164546A Vein-relaxing pain-relieving medicinal composition and preparation method and use thereof |
| 04/23/2008 | CN101164545A Application of asiaticoside in preventing pulmonary fibrosis |
| 04/23/2008 | CN101164544A Helicid powder injection for intravenous drip and preparation method |
| 04/23/2008 | CN101164543A Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 04/23/2008 | CN101164542A Use of mometasone furoate for preparing drug |
| 04/23/2008 | CN101164541A Treatment of urinary dysfunction |
| 04/23/2008 | CN101164540A Application of marine steroids compound in preparing medicine for treating neuronal damage |
| 04/23/2008 | CN101164539A New use of staurosporine derivatives |
| 04/23/2008 | CN101164538A Application of carboxyamido-triazoles compound and its salt in preparing medicine for treating painful diseases and/or inflammatory diseases |
| 04/23/2008 | CN101164537A High-efficient oral silibinin sustained-release preparation and preparation method thereof |
| 04/23/2008 | CN101164536A Apigenin vesicle preparation and its preparation technology |
| 04/23/2008 | CN101164535A Anti-heatstroke use of teprenone |
| 04/23/2008 | CN101164534A Application of curcumin in preparing tumor multi-medicine drug-resistant prevention agent |
| 04/23/2008 | CN101164533A Use of ultrasound contrast agent |
| 04/23/2008 | CN101164532A Duloxetine hydrochloride sustained release medicine |
| 04/23/2008 | CN101164530A Aqueous solution containing stable sodium pyrouvate and preparing method and use thereof |
| 04/23/2008 | CN101164517A Use of benzodihydropyran derivatives in cosmetic or dermatology preparations |
| 04/23/2008 | CN101164436A Method for producing feed for poultry |
| 04/23/2008 | CN101164430A Feed additive for poultry |
| 04/23/2008 | CN100383183C Algae ferment hydrolysate and its producing method |
| 04/23/2008 | CN100383157C 3beta, 5 alpha, 6 beta, 11 beta tetrahydroxy cholestanol, and its preparing method and use |
| 04/23/2008 | CN100383155C Stem clasping gut weed lactone and its derivative composition and its preparing method and its use |
| 04/23/2008 | CN100383149C New crystalline Idedate and its composition |
| 04/23/2008 | CN100383148C Nucleotide analog composition and synthesis method thereof |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383140C Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 04/23/2008 | CN100383139C Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 04/23/2008 | CN100383138C Novel n-monoacylated o-phenylenediamines, their condensed heterocyclic derivatives and their use as pharmaceutical agents |
| 04/23/2008 | CN100383132C Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/23/2008 | CN100383130C Process for resolving aimines that are useful for the treatment of disorders associated with insulin resistance syndrome. |
| 04/23/2008 | CN100383129C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/23/2008 | CN100383128C Ramification of N-carbethoxy cytosine and preparation method and application |
| 04/23/2008 | CN100383126C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 04/23/2008 | CN100383124C Quinoline derivatives as NPY antagonists |
| 04/23/2008 | CN100383118C 4-pyrrolidino-phenyl-benzyl ether derivatives |
| 04/23/2008 | CN100383111C Method for preparing compound of fluoro aromatic hydrocarbon |
| 04/23/2008 | CN100383110C Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
| 04/23/2008 | CN100382846C Method for improved imaging and photodynamic therapy |
| 04/23/2008 | CN100382845C Use of long-acting human recombined soluble TNF alpha receptor in preparation of medicament for treating liver failure |
| 04/23/2008 | CN100382844C Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies |
| 04/23/2008 | CN100382843C Injection for anti-tumor |
| 04/23/2008 | CN100382836C External use traditional Chinese medicinal preparation for treating ringworm of the nails |
| 04/23/2008 | CN100382832C Health foods in use for improving symptom in climacteric period of female |
| 04/23/2008 | CN100382810C Dripping pills used for treating coronary heart disease and its preparation method |
| 04/23/2008 | CN100382805C Azithromycin enteric casing microsphere and its preparing process |
| 04/23/2008 | CN100382804C Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
| 04/23/2008 | CN100382803C Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
| 04/23/2008 | CN100382802C Drug for treating function disorder of autonomic nervous system |
| 04/23/2008 | CN100382801C Pharmaceutical use of alpha-(2,4-dichlorobenzyle)-1H-imidazole-1-ethanol for treating hepatitis |
| 04/23/2008 | CN100382800C Bifendate solid dispersible, and its preparing method and low-release preparation containing same |
| 04/23/2008 | CN100382799C Power for intravenous injection with liver-protecting action, and its preparation and quality control method |
| 04/23/2008 | CN100382798C Pharmaceutical composition containing caffeoylquinic acids |
| 04/23/2008 | CN100382797C Confected product containing lutein and/or carotene linolenic acid, and its preparation method |
| 04/23/2008 | CN100382796C Methods and compositions for providing glutamine |
| 04/23/2008 | CN100382795C Glycinamide derivative for inhibiting HIV replication |
| 04/23/2008 | CN100382794C Dispersed tablet of tartaric acid tolterodine tartrate |
| 04/23/2008 | CN100382793C Novel uses of (E) -4,4íõ-dimethoxy styrene and its composition containing same |
| 04/23/2008 | CN100382782C Release-improved pharmaceutical formulation |
| 04/23/2008 | CN100382710C Preparation method of digestive and Yiwei milk powder with micro-meter Huaguoshan and golden monkey sugar |
| 04/23/2008 | CA2607544A1 A pharmaceutical formulation and its use for the treatment of acquired immune deficiency syndrome (aids) and other aids related diseases and a process for its preparation |
| 04/22/2008 | USRE40259 side effects reduction; compounds active on the central nervous system; chronic and neuropathic pain, anti-epileptic, anti-Parkinson, neuroprotective, antidepressant, antispastic and hypnotic agents; 2-[4-(3-fluorobenzyloxy)benzylamino]-2-methylpropanamide |
| 04/22/2008 | US7361787 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 04/22/2008 | US7361771 Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
| 04/22/2008 | US7361762 Process for preparing acid salts of Gemifloxacin |
| 04/22/2008 | US7361760 Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases |
| 04/22/2008 | US7361758 crystal of a non-solvate of (3R)-1-butyl-2,5-dioxo-3-[(1R)-1-hydroxy-1-cyclohexylmethyl]-9-[4-(4-carboxyphenyloxy)phenylmethyl]-1,4,9-triazaspiro[5.5]undecane hydrochloride; chemokine antagonist |
| 04/22/2008 | US7361756 by mixing 7-hydroxy-tetrahydroquinolinone, dibromobutane, and at least one base to form a reaction mixture; using phase transfer catalysts; or using a low boiling point solvent |
| 04/22/2008 | US7361748 Protease for identifying modulators for treatment and prevention of thrombocytopenia and liver disorders |
| 04/22/2008 | US7361744 Oligosaccharide derivative |
| 04/22/2008 | US7361691 Method of treating cancers using β-lapachone or analogs or derivatives thereof |
| 04/22/2008 | US7361690 Compositions and methods for the treatment of urinary incontinence |
| 04/22/2008 | US7361689 N-amide and haloalkylsulfonyl derivatives of florfenicol; treating or preventing bacterial infections in fish; e.g. 1-(p-fluoromethylsulfonylphenyl)-2-(dichloromethylcarbonylamino)-3-fluoropropanol |
| 04/22/2008 | US7361688 Substituted aminoalcohols useful in treatment of Alzheimer's disease |
| 04/22/2008 | US7361687 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/22/2008 | US7361685 Compounds for use in the treatment of skin conditions |
| 04/22/2008 | US7361684 Screening of compounds for treatment of atherosclerosis and heart attack |
| 04/22/2008 | US7361683 Paclitaxel aqueous injection solution and methods for preparing the same |
| 04/22/2008 | US7361682 Indole derivatives as H3 inverse agonists |
| 04/22/2008 | US7361681 Method of treating amytrophic lateral sclerosis using melatonin |
| 04/22/2008 | US7361680 Indole compounds useful for the treatment of cancer |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361678 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/22/2008 | US7361677 Polycyclic sulphamate compounds suitable for use as inhibitors of aromatase and/or sulphatase |
| 04/22/2008 | US7361676 Solid preparation containing single crystal form |